Cargando…

Value of (11)C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases

PURPOSE: The most common disadvantage of (11)C-choline positron emission tomography and computed tomography (PET/CT) in diagnosing early-stage prostate cancer (PCa) is its poor sensitivity. In spite of many efforts, this imaging modality lacks the ideal parameter of choline metabolism for the diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Shuoming, Fu, Hongliang, Liu, Changming, Zhu, Ziqiang, Zhang, Jiabin, Weng, Wubin, Kang, Jian, Liu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882704/ https://www.ncbi.nlm.nih.gov/pubmed/33598428 http://dx.doi.org/10.3389/fonc.2020.600380

Ejemplares similares

(18)F-DCFPyL PET/CT in Newly Diagnosed Prostate Cancer: Diagnostic Value of Intraprostatic PSMA Uptake in Risk Classification of Prostate Cancer
por: Zhou, Shuoming, et al.
Publicado: (2022)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Clinical Indications of (11)C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
por: Picchio, Maria, et al.
Publicado: (2012)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
por: Matti, A., et al.
Publicado: (2017)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Metabolic Volumetric Parameters in (11)C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer
por: Tseng, Jing-Ren, et al.
Publicado: (2018)

Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse
por: Gómez-de la Fuente, Francisco J., et al.
Publicado: (2019)

Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma
por: Hodolic, Marina
Publicado: (2010)

Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

The Role of [(18)F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [(11)C]Choline PET/CT and Histopathological Analysis
por: Zanoni, Lucia, et al.
Publicado: (2021)

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
por: Deijen, Charlotte L., et al.
Publicado: (2021)

Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review
por: Skanjeti, Andrea, et al.
Publicado: (2011)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
por: Filippi, Luca, et al.
Publicado: (2022)

11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer
por: Wieder, Hinrich, et al.
Publicado: (2017)

The Heterogeneous Metabolic Patterns of Ganglia in (68)Ga-PSMA, (11)C-choline, and (18)F-FDG PET/CT in Prostate Cancer Patients
por: Shi, Yiping, et al.
Publicado: (2021)

Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness
por: Chen, Ji, et al.
Publicado: (2012)

Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer
por: Kawanaka, Yusuke, et al.
Publicado: (2018)

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT
por: Gergelis, Kimberly R., et al.
Publicado: (2019)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
por: Urso, Luca, et al.
Publicado: (2022)

Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?
por: Jadvar, Hossein
Publicado: (2012)

Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer
por: Huang, Shi-ming, et al.
Publicado: (2018)

Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
por: Jedinak, Andrej, et al.
Publicado: (2015)

False-Negative Bone Scan and Choline Pet/Ct Study in a Case of Prostate Cancer: The Pitfall of the Small Cell Prostate Carcinoma Variant
por: Al-Tamimi, Ammad, et al.
Publicado: (2012)

Accuracy of tumor segmentation from multi-parametric prostate MRI and (18)F-choline PET/CT for focal prostate cancer therapy applications
por: Piert, Morand, et al.
Publicado: (2018)

(18)F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
por: Urbano, Nicoletta, et al.
Publicado: (2019)

DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia
por: Kim, Stephanie S., et al.
Publicado: (2023)

Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical Implications
por: Welch, Brian T., et al.
Publicado: (2018)

[(11)C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy
por: Schwarzenböck, Sarah M., et al.
Publicado: (2016)

Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment
por: Wei, Junbao, et al.
Publicado: (2018)

Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis
por: Guo, Yu, et al.
Publicado: (2018)

The Added Value of [(18)F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report
por: Piras, Antonio, et al.
Publicado: (2022)

PET/CT in Prostate Cancer
por: Evangelista, Laura, et al.
Publicado: (2023)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
por: Niyazi, Maximilian, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vdo14eleqcd784tgg8i9h7luf6